EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 4.0

Prevalence of drug resistance mutations in low-level viremia patients under antiretroviral therapy in Southwestern China: a cross-sectional study

Yuanlu Shu, Jiafa Liu, Cuixian Yang, Jianjian Li, Mi Zhang, Yuan Li, Xuemei Deng, Xingqi Dong

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf017 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Yuanlu Shu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Kunming Medical University, Kunming 650500, China. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Drug Resistance, Viral, Viremia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Major Science and Technology Project of Yunnan Provincial Science and Technology Department, Talents Project of Yunnan Provincial Science and Technology Department, Reserve Talents Project of Yunnan Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to evaluate the prevalence and characteristics of drug resistance mutations (DRMs) in patients with low-level viremia (LLV) in Southwestern China, as it has become a growing challenge in AIDS clinical practice.

Methods

This cross-sectional study was performed in Yunnan Province, Southwestern China. LLV was defined as 50–999 copies/mL of plasma viral load with antiretroviral therapy (ART) for at least 6 months. HIV-1 DRM detection used validated in-house protocol.

Results

A total of 470 sequences were obtained, and 13 HIV-1 genotypes were identified, among which CRF08_BC (47.5%), CRF07_BC (22.3%) and CRF01_AE (10.0%) subtypes were the most prevalent. The overall prevalence of DRMs was 45.7% (215/470), and the prevalence of DRMs to non-nucleoside reverse transcriptase inhibitors (NNRTIs), nucleoside reverse transcriptase inhibitors (NRTIs) and protease inhibitors (PIs) was 39.4% (185/470), 20.6% (97/470) and 5.3% (25/470), respectively. The most common NNRTI-associated mutations were K103N (16.0%), E138A (6.6%), V179D (6.6%) and P225H (4.9%), and those in NRTIs were M184V (17.0%), D67N (3.4%) and K65R (3.0%). PI-associated mutations were infrequent, occurring in less than 1.8% of cases. The prevalence of NNRTI-associated mutations (K101E and Y188C) was found to be statistically significant among various LLV groups. Additionally, significant variations were observed in the prevalence of NNRTI-associated mutations (V106I, V106M, E138A and P225H), NRTI-associated mutation (K65R) and PI-associated mutations (L33F and Q58E) across different subtypes.

Conclusions

The prevalence of DRMs in ART-experienced patients with LLV was high, and HIV-1 genotypes exhibited diversity in Yunnan Province. These findings indicate that regular DRM monitoring during LLV episodes was essential for effective clinical treatment and management in this region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsDrug Resistance, ViralViremiaMutationAnti-HIV AgentsHumansCross-Sectional StudiesChinaMaleFemalePrevalenceAdultMiddle AgedGenotypeViral LoadYoung AdultAntiretroviral Therapy, Highly Active

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • School of Public Health, Kunming Medical University, Kunming 650500, China.
  • Department of Laboratory Medicine, Yunnan Provincial Infectious Disease Hospital, Kunming 650301, China.
  • Department of Public Health, Yunnan Provincial Infectious Disease Hospital, Kunming 650301, China.
  • Department of Science and Education, Yunnan Provincial Infectious Disease Hospital, Kunming 650301, China.

Förderung

  • Major Science and Technology Project of Yunnan Provincial Science and Technology Department
  • Talents Project of Yunnan Provincial Science and Technology Department
  • Reserve Talents Project of Yunnan Provincial Health Commission
  • Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University
  • Kunming Medical University AIDS

Zitieren

APA

Shu, Y., Liu, J., Yang, C., Li, J., Zhang, M., Li, Y., Deng, X., & Dong, X. (2025). Prevalence of drug resistance mutations in low-level viremia patients under antiretroviral therapy in Southwestern China: a cross-sectional study. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf017

Vancouver

Shu Y, Liu J, Yang C, Li J, Zhang M, Li Y, et al. Prevalence of drug resistance mutations in low-level viremia patients under antiretroviral therapy in Southwestern China: a cross-sectional study. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf017

BibTeX
@article{Shu2025,
  author = {Shu, Yuanlu and Liu, Jiafa and Yang, Cuixian and Li, Jianjian and Zhang, Mi and Li, Yuan and Deng, Xuemei and Dong, Xingqi},
  title = {Prevalence of drug resistance mutations in low-level viremia patients under antiretroviral therapy in Southwestern China: a cross-sectional study},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf017}
}
Kostenlos starten →